Link Cell Therapies

Stanford, United States · Founded 2022 · $72.0M raised

Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$72.0M
Last Round
$60.0M Series ADec 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Link Cell Therapies was launched by Stanford founders Robbie Majzner and Crystal Mackall in partnership with Samsara BioCapital to develop safe and effective CAR T agents for patients with solid tumors. Its unique logic-gate technology enables AND-gate CAR Ts that require co-expression of cancer targets to drive cell cytotoxicity, providing greater specificity for tumor than existing logic-gate technologies. Combined with additional platforms under development, the company is advancing therapeutic programs across multiple cancer indications including solid tumors and certain hematologic cancers.

Summary

Link Cell Therapies is a Biotech company based in Stanford, United States, founded in 2022. It has raised $72.0M in total across 2 rounds, most recently a $60.0M Series A round in Dec 2025. Investors include Johnson & Johnson Innovation and Samsara BioCapital.

Tech & App Stack

Funding History

Series ASeries ADec 2025
$60.0M

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Avenzo

Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...

San Diego, United States1–10Biotech, Oncology
Series BTotal funding$832.0MSep 2025
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech, Oncology
Private EquityTotal funding$607.0MJan 2024
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Link Cell Therapies on Indexed.vc
<a href="https://indexed.vc/companies/link-cell-therapies"><img src="https://indexed.vc/api/badge/company/link-cell-therapies" alt="Link Cell Therapies on Indexed.vc" width="260" height="76" /></a>